Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Vascular Surgery|April 13, 2020
Survival after endovascular therapy in patients with ruptured thoracic aortic diseases: Results from the Global Registry for Endovascular Aortic Treatment RegistryKenneth Walsh, David J O'Connor, Fred Weaver, et al.
Surgery|August 4, 2022
Age disparities in triple-negative breast cancer treatment and outcomes: An NCDB analysisLauren M Drapalik, Ashley Estes, Anuja L Sarode, et al.
Annals of Surgical Oncology|August 3, 2021
Neoadjuvant Endocrine Therapy as an Alternative to Neoadjuvant Chemotherapy Among Hormone Receptor-Positive Breast Cancer Patients: Pathologic and Surgical OutcomesLifen Cao, Kavin Sugumar, Eleanor Keller, et al.
JTO Clinical and Research Reports|April 11, 2022
Sex Differences in Lung Cancer Treatment and Outcomes at a Large Hybrid Academic-Community PracticeNickolas Stabellini, Debora S Bruno, Mantas Dmukauskas, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|May 17, 2020
Cell-free DNA as a biomarker for colorectal cancer: a retrospective analysis in patients before and after surgeryYubing Zhong, Qing Zhou, Yun Zhang, et al.
The Journal of Surgical Research|November 27, 2022
Modeling the COVID Pandemic: Do Delays in Surgery Justify Using Stereotactic Radiation to Treat Low-Risk Early Stage Non-Small Cell Lung Cancer?Lifen Cao, Philip A Linden, Tithi Biswas, et al.
JNCI Cancer Spectrum|February 8, 2023
Allostatic load and cardiovascular outcomes in males with prostate cancerNickolas Stabellini, Jennifer Cullen, Marcio S Bittencourt, et al.
Molecular Cancer Therapeutics|July 26, 2013
Catalase abrogates β-lapachone-induced PARP1 hyperactivation-directed programmed necrosis in NQO1-positive breast cancersErik A Bey, Kathryn E Reinicke, Melissa C Srougi, et al.
Antioxidants & Redox Signaling|February 12, 2014
Tumor-selective, futile redox cycle-induced bystander effects elicited by NQO1 bioactivatable radiosensitizing drugs in triple-negative breast cancersLifen Cao, Long Shan Li, Christopher Spruell, et al.
Pageof 2